Objective: The aim of this study was to evaluate cost-effectiveness of Acceptance and Commitment Therapy (ACT) and workplace dialogue intervention (WDI), both as stand-alone interventions and in combination, compared with treatment as usual (TAU), for employees on sickness absence with mental disorders. Methods: Employees (n ¼ 352, 78.4% females) on sickness absence were randomized to one of four groups. Cost-utility analyses were conducted from a health care perspective and a limited societal perspective. Results: All groups reported significant improvements in health-related quality-of-life (HRQoL) and there were no significant differences in HRQoL or costs between groups. The probability of costeffectiveness for ACTþWDI was 50% compared with ACT, indicating that both treatment alternatives could be considered equally favorable for decision-makers. TAU and WDI were rejected due to less economic efficiency. Conclusion: Adding WDI to ACT cannot be recommended on the basis of our study results.
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BACKGROUND
C ommon mental health disorders, including depression, anxiety, and reaction to severe stress, are the leading causes of sickness absence in most high-income countries. The total cost of sickness absence to society has been estimated to be 3% to 4% of the gross domestic product in European countries. 1 More than half of these costs refer to welfare benefits, lost employment, and lost productivity at the workplace. 1, 2 Depressive disorders are expected to be the leading cause of disability-adjusted life years (DALYs) in high-income countries by 2030, 3 implying high societal costs. The societal cost of depression in Sweden (for 2005) was estimated at 400 million EUR, with 50 million relating to health care costs, and 350 million relating to productivity losses (sickness absence and premature death). 4 Evidence-based interventions, such as pharmacological treatments and psychotherapy, are effective in treating common mental disorders; however, these have failed to show effect on decreasing sickness absence rates and increasing return-towork. [5] [6] [7] [8] Effective interventions for reducing sickness absence due to mental health disorders are, therefore, increasingly important. Moreover, the need for evaluating the cost-effectiveness of evidence-based interventions is crucial in order to inform policymakers about the optimal allocation of health care resources and meet the increasing need of mental health care. Combining psychotherapy, often cognitive behavioral therapy (CBT), with a workplace intervention, that is, work-focused CBT or CBT in combination with a workplace intervention, is one example of new treatment approaches aimed at improving mental health in the workplace and decreasing sickness absence. 9, 10 We recently conducted a study wherein the effect of three interventions was evaluated: (1) Acceptance and Commitment Therapy (ACT), (2) a workplace dialogue intervention (WDI) and, (3) a combination of ACT and WDI, compared with treatment as usual (TAU), for employees on sickness absence due to common mental disorders. 11 The study hypothesis was that ACT would improve mental health and that adding WDI to ACT would also result in less sickness absence as a consequence of targeting obstacles to RTW through improved communication with the supervisor.
ACT is a newer branch within CBT that emphasizes mindfulness and acceptance strategies and incorporates the clients' personal values as a means to increase participation in meaningful behavior. 12 ACT has been evaluated for a broad range of health conditions, [13] [14] [15] and in work-related settings with promising results for preventing sickness absence. 16 Few studies have investigated the cost-effectiveness of CBT treatment for mental disorders with regard to return to work (RTW), and even fewer the cost-effectiveness of ACT. A recent study comparing an ACT intervention in group format to drug prescription and a wait-list control found ACT to be cost-effective from both a health care perspective and a government perspective for fibromyalgia. 17 Another study found ACT to be potentially cost-effective for long-standing pain 18 and internet-delivered acceptance and values-based exposure therapy has been found cost-effective for fibromyalgia. 19 However, to our knowledge, there are no studies on the cost-effectiveness of ACT for mental disorders to date.
The WDI aims at improving communication between the employee and a supervisor through a series of meetings and has previously shown positive results on RTW for work-related stress. 20, 21 At 18 months follow-up, a larger proportion of participants in the intervention group had returned to work compared with the control group. Nonetheless, in terms of cost-effectiveness, systematic review concluded that preventive worksite interventions showed a potentially favorable financial return, but due to low study quality, the results were uncertain. 22 The same review concluded that RTW work-place interventions did not show favorable costeffectiveness or cost-benefit balance. 22 Summing up, there is an overall lack of studies on the costeffectiveness of interventions for employees with mental disorders on sickness absence. Further, there are no prior studies on the costeffectiveness of stand-alone ACT and WDI, or ACT and WDI in combination. Cost-effectiveness implies that competing interventions are compared with regard to their health gain in relation to their costs. 23 Information on both costs and effects is needed to determine the value-for-money credentials of these interventions, and help guide decisions on how to distribute resources between competing treatment options, in order to make optimal use of public means. Further, in order to inform policy makers both at a health care level and a societal level, different perspectives need to be applied where the first perspective comprises health care costs only and the second perspective also includes costs for welfare benefits. The aim of this study was to evaluate the cost-effectiveness of an ACT intervention, a WDI, and a combination of ACT and WDI, all compared with TAU. The target group was employees on sickness absence due to a common mental disorder. The costeffectiveness analyses were performed from two perspectives: a health care perspective and a limited societal perspective including welfare benefits.
METHODS

Randomized Trial Study Design
This economic evaluation is based on data collected from a randomized controlled trial (RCT) at the following assessment points: baseline, post-treatment, three (3MFU), and nine (9MFU) months follow-up. The trial was registered at http://clinicaltrials.gov (Trial registration number: NCT01805583) and was approved by the Regional Ethical Review Board in Stockholm (Dnr 2012/2109-31/ 5). More detailed information on the study design, procedure, and outcomes has been presented elsewhere.
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Study Population
Participants were recruited via the Swedish Social Insurance Agency between April 2013 and June 2014. Inclusion criteria for eligible participants were: be in working age, reside in Stockholm county, have a current employment status of at least 50%, and have been on sickness absence (full-or part-time) for the past 1 to 12 months due to an anxiety disorder, depression, reaction to severe stress or adjustment disorder (in the present paper referred to as exhaustion disorder). Exclusion criteria were severe depression, history of bipolar disorder or psychosis, substance abuse or dependence, current unemployment or self-employment, and insufficient comprehension of the Swedish language.
Interventions Evaluated
ACT
12 is a psychological intervention within the frame of third wave behavior therapies. A manual consisting of six 60-minutes sessions was created for this project based on the six core ACT processes. The first part of the manual (sessions 1 to 3) emphasized mindfulness, cognitive defusion, and acceptance. During sessions 4 to 6, the focus was on exploring and clarifying personal values and committing to pursuing valued life activities. Experiential exercises and behavioral exposures were a regular part of all sessions to practice making room for emotions, thoughts, and bodily sensations, and to practice engaging in valued activities while experiencing symptoms or other discomfort.
The WDI intervention was developed from the original intervention presented by Karlson et al, 20 comprising three meetings involving the participant and his or her supervisor at work. In the original study, these meetings followed a team assessment and were complemented with voluntary half-day seminars about work-related stress and sickness absence for participants and supervisors. In the current study, the first step was an individual interview with the participant at the clinic followed by an interview with the participants' supervisor at the workplace. These meetings, lasting up to 60 minutes, aimed to investigate the participants' and the supervisors' views upon causes of the sickness absence, and what might facilitate RTW. The third meeting, also at the workplace, lasted up to 90 minutes, and consisted of a so-called convergence meeting, including the participant, the supervisor, and the project therapist. The aim for this meeting was to initiate a dialogue between the patient and the supervisor to find solutions to facilitate RTW.
ACTþWDI consisted of the two interventions as described above, conducted by two different therapists. There was no integration or coordination of the two interventions, and no interaction between therapists was included in the protocol. TAU participants were informed after randomization that they would continue treatment as it was planned at their primary care center or other care facility. They answered questionnaires at the same assessment points as the other groups, but did not receive any intervention within the study. TAU included any intervention or consultation as offered by the primary care center or other care facility. All participants meet with a physician for sickness absence certification. Furthermore, this population is typically offered psychotherapy, most commonly cognitive behavior therapy, and/or pharmacological treatments but also physical therapy and counseling.
The duration of all study interventions was 3 months when post-measurement took place. During this period, participants in ACT, WDI, and ACTþWDI were instructed not to engage in other similar treatments, that is, psychotherapy of any form. However, in some cases, due to practical reasons, the intervention period was prolonged. In these cases, post-measurements were performed upon treatment completion. The mean intervention time was 10 weeks (SD ¼ 3.8) for ACT, 9.3 weeks for WDI (SD ¼ 4.0), and 12.7 weeks for ACTþWDI (SD ¼ 4.7). For the TAU group, post-measurement was performed 3 months after randomization.
Economic Evaluation
Cost-effectiveness analysis is a branch of health economics concerned with the comparative analysis of the incremental differences in costs and effects of alternative interventions. 23 The result of the analysis is usually presented as an incremental cost-effectiveness ratio (ICER), where the difference in costs is divided by the difference in effects of the alternatives being compared. A cost-utility analysis is a type of cost-effectiveness analysis, where health effects are measured in quality-adjusted life-years (QALYs). 23 The economic framework of this study is a cost-utility analysis, where the interventions ACT, WDI, ACTþWDI, and TAU were compared with regard to their costs and effects. The analysis was undertaken from two perspectives: (1) a health care perspective, including intervention costs and health care costs impacted by the interventions, and (2) a limited societal perspective, including additionally sickness benefits. The time horizon for the evaluation is 12 months, reflecting the time from baseline assessment at randomization, to the last follow-up assessment at 12 months from baseline.
COST ANALYSIS
Two categories of costs were estimated, intervention costs (setup and operating costs), and other societal costs (health care costs and sickness benefits). Setup costs include costs for preparation of treatment protocols and costs for training and supervision. Operating costs represent the costs of running the interventions. Health care costs comprise the cost of health care resources used during the study period, including costs for health care visits to different professionals. Pharmacological costs were not included. Sickness benefits comprise state insurance benefits due to sickness during the study period. The volumes of each cost category were obtained from study records, and unit costs were obtained from national public databases and websites (see Table 1 ). Patients' time to attend the interventions was not included in the analysis. Costs were collected in 2015 prices, adjusted for inflation, and presented in US dollars using purchasing power parities for gross domestic product. 24 Finnes et al JOEM Volume 59, Number 12, December 2017
Interventions Costs
Set-up and training costs were calculated for both protocols separately. The WDI protocol was adapted from a protocol used in a previous trial 20 in collaboration with the authors of the original study. Time costs were estimated on the basis of ordinary hourly wage including social charges of 44.54%. Training costs include hourly wage for time spent in training and supervision for trainers and attendees. The wage for the psychologists was based on the mean wage for clinical psychologists in Sweden. 25 Average treatment costs per person were calculated by dividing the total cost by the number of participants that initiated treatment in each group. Total intervention costs included only 20% of the protocol costs and total training costs to represent the spread of the costs over a 5-year period before reaccreditation. More detailed information on set-up and training costs can be found in Supplement 1, http://links.lww.com/JOM/A358.
Operating costs represent the cost of running the programs. These include salaried time for therapist's running the sessions and administration, and transportation costs for therapists traveling to work sites. Average hourly costs for a psychologist were estimated on the basis of the national mean wage for that professional category. 25 
Other Societal Costs
Health care costs were based on estimated cost per visit to health professionals in Stockholm County from the Cost per Patient Database. 26 Participants estimated the number of visits to different health professionals through questionnaires at 3, 6, and 12 months follow-up. Sickness benefits costs were collected from the Social Security Office register, comprising the total amount of state insurance benefits that were paid to each individual during the project period.
HEALTH OUTCOMES
The EuroQol (EQ-5D) instrument was used to measure the health outcomes of the interventions. The EQ-5D measures health related life quality in relation to five domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, where each domain contains three levels of response: no problems, some problems, major problems. The answers given were combined to generate a summary score, expressed as an index of health-related quality-of-life on a scale from 0, representing death, to 1, full health. 27 QALYs were calculated by applying a population-based index weight, as proposed by the EuroQol group. 28 QALYs gained were calculated for each participant using the changes in utilities at every assessment point, from baseline until 12 months follow-up.
Statistical Analyses
All statistical analyses followed the intention-to-treat (ITT) principle. Baseline characteristics and utilities were compared between groups using one-way analysis of variance (ANOVA). For health care utilization and health effects (EQ-5D), overall rates of missing values differed somewhat between groups and between measurement points: at post (25.2% in ACT, 41.6% in WDI, 27.3% in ACTþWDI, 27.5% in TAU); at 3MFU (17.9% in ACT, 33.7% in WDI, 22.6% in ACTþWDI, 23.6% in TAU); and at 9MFU (10.7% in ACT, 21.5% in WDI, 11.0% in ACTþWDI, 13.4% in TAU). Overall, there were more missing data points in the WDI group. In order to incorporate all available information regarding resource use and clinical parameters, multiple imputations were employed, using MPlus 7.11 statistical software. 29 Fifty imputed datasets were created based on data from all measurement points. Costs were calculated subsequently according to the procedures described before (see Supplement 1, http://links.lww.com/JOM/A358). For each of the four treatment groups, mean costs and EQ-5D values (outcomes) were calculated in 5000 bootstrapped subsamples for each of the 50 imputed datasets, thus resulting in 250,000 values for each treatment group for each cost and for EQ-5D. These values were organized in a random order in a dataset and the differences in costs and in outcomes (EQ-5D) between the groups were calculated. The standard errors for these differences were calculated using Rubin's rule. 30 The predicted monthly increase in EQ-5D (slope) for each group, and the significance of the difference in slope between groups, was calculated with Latent Growth Modeling using MPlus 7.11 statistical software.
COST-UTILITY ANALYSIS
Treatment options were first ranked in an ascending order of cost compared with a ''null comparator'' option, assuming zero costs and effects. ICERs were calculated using the general formula
, where D C1 ÀD C2 is the difference in cost between the two conditions being compared and D E1 ÀD E2 refers to the difference in the average effectiveness between the options. 23 All dominated (lower effect to a higher cost) options were excluded before final ICERs were estimated. The ICER informs about the costs associated with one intervention achieving an additional QALY compared with the next best treatment alternative. If one intervention is more effective and more costly than the other alternative, its cost-effectiveness depends upon society's maximum willingness-to-pay (WTP) per unit of health gain.
Nonparametric bootstrapping was performed with 5000 iterations per dataset to generate confidence intervals (CIs) for the mean incremental costs and effects, and to estimate the uncertainty around the ICERs. The corresponding bootstrapped estimates were pooled into one set of estimates. This way, the correct formula for pooling the estimates can be used to retain the between imputation variance, and correctly estimate the within imputation variance. The results are presented graphically on the cost-effectiveness plane and as costeffectiveness acceptability curves (CEACs). The cost-effectiveness plane illustrates the incremental effect on the x-axis and the incremental cost on the y-axis, dividing the plane into four quadrants. Each quadrant has a different implication for decision-making. The southeast corner implicates lower costs and higher effects. Interventions falling in this quadrant are considered cost-effective. Interventions that fall in the northwest quadrant imply higher costs and lower effects. Interventions that fall in this quadrant are never considered cost-effective. The northeast quadrant, with higher costs and higher effects, and the southwest quadrant, with lower costs and lower effects, are associated with the need to consider trade-offs. In these cases, cost-effectiveness depends upon the value at which the ICER is considered good value-for-money. This is further illustrated in the CEAC, which shows the probability that each treatment option is more cost-effective than the other treatments at different levels of WTP. CEACs were constructed by calculating how many of the observations fell in the southeast quadrant, when successively increasing the allowed difference in cost between treatments (imagine moving the x-axis from zero and upward in the upper panels in Fig. 1 ).
SENSITIVITY ANALYSIS
Sensitivity analyses were carried out in order to investigate the robustness of the cost-effectiveness results. In the first sensitivity analysis, the English utility weights 28 used in the main analysis were replaced by Swedish utility weights. 31 Second, corresponding to a scenario where the interventions are delivered in regular care, the intervention costs were recalculated based on the estimated cost per visit in Stockholm County Council. In this scenario, all meetings took place in the therapist's office, hence saving the costs of traveling to the workplace in the WDI intervention. Third, a perprotocol analysis was conducted including only those who completed the treatments according to the protocols [ACT ¼ 71 (78.9%), WDI ¼ 47 (55.3%), and ACT þ WDI ¼ 61 (70.9%)]. Finally, the last sensitivity analysis was conducted based on subgroup analyses for diagnostic groups to control for important variation in costeffectiveness. 32 Hence, the treatment conditions were compared separately for participants with exhaustion disorder and depression/ anxiety disorders.
RESULTS
Attrition and Baseline Characteristics
Of the 777 applicant inquiries that underwent phone screening, 449 appeared eligible and participated in an in-person diagnostic interview. Ninety persons were excluded according to inclusion and exclusion criteria. A total of 359 participants were randomized into one of the trial arms (ACT ¼ 90, WDI ¼ 90, ACT þADA ¼ 90, and TAU ¼ 89). Seven participants were later withdrawn when either further information indicated problems with eligibility or the participant declined further participation (ACT ¼ 1, WDI ¼ 3, ACT þ WDI ¼ 2, TAU ¼ 1). The final sample size was composed of 352 participants, ACT (n ¼ 89), WDI (n ¼ 87), ACTþWDI (n ¼ 88), or TAU (n ¼ 88). Out of these, 220 participants started treatments in the treatment groups, ACT (n ¼ 82), WDI (n ¼ 62), or ACT þ WDI (n ¼ 76), and 185 participants completed treatment according to the study criteria, ACT (n ¼ 76), WDI (n ¼ 47), and ACTþWDI (n ¼ 62). Regarding questionnaires, 240 (68.2%) participants completed them at all four measurement points, ACT (74.2%), WDI (54%), ACTþWDI (70.5%), and TAU (73.9%). There were no significant differences at baseline between the four groups regarding descriptive data, outcome measures, or costs.
Intervention Costs
Setup costs and training costs amounted to $37 per participant in the ACT group, $34 for WDI, and $67 for ACTþWDI. Operating costs were the major cost driver, with ACTþWDI having the greatest cost for session time. Operating cost for the ACT group was $284 per participant, and for WDI $354. Although WDI is a shorter intervention with fewer sessions, travel time added to the total time used by the therapist. The ACTþWDI group had the highest total operating cost per participant, $638, with total session time amounting to a bigger component of the cost. Table 1 presents a summary of these costs. In total, ACTþWDI entailed the highest intervention cost, $705 per participant, and ACT the lowest, $321 per participant.
Other Societal Costs
Health Care Costs
Health care costs included costs for visits to medical doctor, psychologist, social worker, physical therapist, and nurse beside the study interventions. Means and standard deviations for the health care costs are presented in Table 2 . Median costs are also provided due to skewed data. The ACT group had the lowest cost per participant, with a mean cost of $5185, followed by ACTþWDI ($5435), the WDI group ($6076), and TAU ($6207). There were no significant differences in health care costs between groups (Table 3) .
Sickness Benefits
Total sickness benefits were compared between groups ( Table 2 ). The ACT group had the lowest average cost per participant ($8944), followed by the WDI group ($9184), TAU ($9385),
FIGURE
1. Cost-utility planes for ACTþWDI compared with ACT from the health care perspective and the limited societal perspective. The percentage of bootstrap iterations for each of the four quadrants is specified.
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and the ACTþ WDI group ($10,923). There were no statistically significant differences in sickness benefits cost between groups (Table 3) .
Health Outcomes
Means and standard deviations of EQ-5D index at baseline-, post-, 3MFU, and 9MFU are presented in Table 2 . There was no statistically significant difference between groups for EQ-5D values at baseline (P > 0.1). Slope estimates indicated a monthly increase of HRQoL of 0.01 for ACT, 0.008 for WDI, 0.012 for ACTþWDI, and 0.013 for TAU. Change over time was significant in all groups (for ACT, ACTþWDI and TAU: P < 0.001; for WDI P < 0.01), but there was no significant interaction effect in estimated average linear change over time between interventions (P > 0.05), indicating similar improvement rates across groups.
Cost-Utility Analysis
Health Care Perspective
Considering the health care perspective, ACT and ACTþWDI were dominant treatment alternatives with lower costs and higher effects (see Table 4 ). The WDI and TAU groups were both dominated, that is, generated lower effects and higher costs than ACT and ACTþWDI. ACT, being the least expensive treatment option, generated an ICER of $33,579 per additional QALY gained compared with the ''null comparator.'' This suggests that the cost of a QALY gained for the ACT group is below the Swedish threshold of cost-effectiveness of $57,000 (equivalent to 500,000 SEK). 33 The next best alternative was ACTþWDI with an ICER of $158,500 per additional QALY gained, which lies above the WTP threshold. Figure 2 presents the scatter of simulated ICERs for ACTþWDI compared with ACT across the four quadrants of the cost-effectiveness plane indicating the degree of uncertainty around the ICERs. In this figure, we can see that the uncertainty iterations for the differences between the interventions are spread over all four quadrants of the plane. This indicates the uncertainty around the cost-effectiveness estimates of the combined therapies ACTþWDI compared with ACT. Figure 1 shows the CEACs displaying the probability of one treatment being cost-effective according to different WTP thresholds. There is a 60% probability of ACT being more cost-effective than doing nothing when WTP is $6650, which increases to 75% if WTP is $14,000. For ACTþWDI compared with ACT, the probability of cost-effectiveness reaches a maximum of 50% at a WTP of $11,000.
Limited Societal Perspective
From a limited societal perspective, including costs for sickness benefits, the WDI and TAU groups were dominated. The ICER for ACT was $88,122, followed by ACTþWDI with an ICER of $653,500 (see Table 5 ). In Fig. 2 , we can see that the uncertainty iterations for both interventions are spread over all four quadrants of the plane. CEACs (Fig. 1) indicate 75% probability of cost-effectiveness for ACT compared with doing nothing, and 50% probability of cost-effectiveness for ACTþWDI compared with ACT.
Sensitivity Analyses
Overall, QALY gains using Swedish weights were smaller in all groups than in the English weights. However, all other treatment options were dominated, that is, less effect to a higher cost, in relation to ACT, which yield an ICER of $55,070 for the health care perspective (see Table 4 ) and an ICER of $144,520 for the limited societal perspective (see Table 5 ).
The analysis on intervention costs based on the estimated cost per visit in Stockholm County Council yield an intervention cost of $1788 for ACT, $894 for WDI and, $2682 for ACTþWDI. Overall, differences between groups in mean costs were nonsignificant from both the health care and the limited societal perspective (all P > 0.1). In this scenario from a health care perspective, WDI was again dominated and excluded from the analysis. TAU generated an ICER of $40,045 compared with the null comparator (see Table 4 ). The cost of an additional QALY gained was $85,222 for ACT compared with TAU, and $286,000 for ACTþWDI compared with ACT. From a limited societal perspective, the overall pattern was similar. TAU generated an ICER of $100,600/QALY gained, followed by ACT (ICER ¼ $36,222/QALY gained) and ACTþWDI (ICER ¼ $781,000/QALY gained).
A per-protocol analysis showed that ACT was the treatment alternative that yields the lowest cost and the highest effect. The other treatment alternatives were dominated. ACT yields an ICER of $27,740 per QALY gained from the health care perspective, and $76,497 per QALY gained from the societal perspective.
Finally, regarding the subgroup analyses for the diagnostic groups, for participants with exhaustion disorder, ACT was the most cost-effective treatment alternative from the health care perspective ($41,086/QALY gained), generating the highest effects and the lowest cost. The other treatment alternatives were dominated. From the limited societal perspective WDI was the least expensive treatment, generating an ICER of $121,588 per QALY gained ( Table 5 ). The cost of an additional QALY for ACT compared with WDI was $33,192. For depression/anxiety disorders, ACT was the least expensive treatment from both the health care perspective (ICER ¼ $29,787/QALY gained) and the limited societal perspective (ICER ¼ $80,122/QALY gained). ACT, acceptance and commitment therapy; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-years; TAU, treatment as usual; WDI, Workplace Dialogue Intervention.
Finnes et al
DISCUSSION
This study investigated the cost-effectiveness of two short interventions, from both a health care and a limited societal perspective, within the context of a RCT. The results showed that there were few differences between the four treatment alternatives compared, ACT, WDI, ACTþWDI, and TAU, in terms of costs and impacts on HRQoL. Comparisons between intervention groups did not reveal any significant differences in mean health care and societal costs over the study period of 1 year. Participants in all groups significantly improved HRQoL during the study period. The cost-effectiveness analyses showed that ACT was cost-effective from the health care perspective, but not from the limited societal perspective, according to the Swedish WTP threshold of $57,000. Adding WDI to ACT was not cost-effective from either of the perspectives. The CEAC showed that regardless of the level of willingness to pay, the probability of cost-effectiveness for ACTþWDI barely exceeds 50%, indicating that both ACT and ACTþWDI could be considered equally favorable for decisionmakers. Stand-alone WDI and TAU were dominated from both perspectives. Sensitivity analyses were conducted in order to test the robustness of the base-case analysis results. These further revealed the uncertainty in the differences between groups. When intervention costs were replaced with mean costs per visit, TAU had the lowest cost from both the health care and the limited societal perspective, although differences were still not significant. In addition, subgroup analyses did not reveal significant differences between groups that had any major impact on the CEAC results.
The cost-effectiveness of ACT has previously been evaluated in relation to chronic pain treatment and the results showed that ACT was more cost-effective than drug-prescription for fibromyalgia 17 and that ACT were more cost-effective than applied relaxation at post and 3 months follow-up but not at 6 months follow-up. 18 However, this current study is, to our knowledge, the first to examine the cost-effectiveness of ACT for mental health disorders, and particularly for employees on sickness absence due to mental disorders. Further, there are no prior studies examining the costeffectiveness of combining a workplace intervention with ACT or of the WDI examined in this study. In recent years, several studies have been published looking at the cost-effectiveness of worksite RTW interventions for employees on sickness absence. [34] [35] [36] [37] [38] Unfortunately, the comparison between studies is complicated by differences in study population, type of intervention, and effect measures. However, a general trend is that there is no economic benefit of the RTW interventions compared with a control condition, 22 which is in line with the current study results.
Regarding clinical effectiveness, WDI did not focus on symptoms but on improving communication with the supervisor in order to improve functioning in the workplace. Hence, the lack of effect on symptoms or health-related quality of life in the WDI group should not be surprising. Adding ACT to WDI improved health effects but not significantly more than the stand-alone ACT intervention. Also, in contrary to the study hypothesis, the combined treatment alternative did not produce significantly lower sickness benefit costs in comparison to the three other treatment alternatives. This might be due to clinical limitations in simply adding but not sufficiently integrating the two interventions. We decided to individualize the two interventions for two reasons. First, we specifically wanted to study the add-on effect of a workplace intervention to psychotherapy, and second, the WDI manual stressed the importance of an impartial and equal relation between the participant and the supervisor. If the same therapists also conducted ACT, this balance of equality in the relationship between the participant and the supervisor might have been disrupted. However, the current design may have prevented a cumulative effect that a stronger integration between the two treatment approaches might have produced. Nevertheless, in a recent study, the so-called convergence dialogue, a central part of the WDI intervention, was integrated with work-focused CBT in a RTW intervention. 39 Although a small difference in time to RTW favoring the CBT and convergence dialogue alternative, time to full RTW was longer than for CBT alone. Despite the nonsignificant differences between groups in de Weerd et al, 38 the overall results for the combined treatment go in the same direction as in the current study. Adding a short intervention that includes dialogue with the supervisor at the workplace does not seem to improve RTW outcomes. A more thorough effort including follow-up and support of any change processes that might be initiated as a result of the WDI may yield different results. This should be considered in future studies of RTW interventions where different interventions are combined.
There are some important strengths to this study. Other than being the first study to evaluate the cost-effectiveness of ACT and WDI for employees on sickness absence due to mental disorders, there is also a lack of economic evaluations of RTW interventions overall. Including QALYs as an effect measure is of particular importance to allow for comparisons among other health interventions that might be considered within the same budget. Other strengths of the present study are the randomized design with four different interventions, including TAU, the relatively large sample, and the long follow-up period of 12 months. Also, complete and blindly retrieved register data on sickness benefits allowed for a reliable estimation of societal costs. There are also some methodological limitations that need to be considered. First, while the register-based inclusion of participants allowed us to invite all individuals on sickness absence to the study, the exclusion of unemployed and self-employed individuals limit the generalizability of the study results to the employees. Second, data on health care FIGURE 2. Cost-effectiveness acceptability curves comparing the treatment alternatives from a health care perspective (to the left) and from a limited societal perspective (to the right).
resources used were collected based on retrospective, self-reported questionnaires, which may have underestimated the results due to potential recall biases. Third, the limited societal perspective represents a limitation. In order to fully include the impact of an intervention, costs and benefits from different sectors should be included, as a societal perspective can detect costs and benefits shifting between sectors. For this study, it is possible that there were significant cost and benefits related to the workplace that was not included. Also, drug costs and opportunity costs for participant's time were not included. Another limitation is the missing data due to loss to follow-up. This was handled statistically by multiple imputations, which adverted the missing data problem. However, due to skewed cost data, this might have resulted in a ''regression to the mean'' effect on a group level. In regard to the effect measure, the dominance of physical health in the EQ-5D has raised questions on whether EQ-5D is sensitive enough to capture an effect on mental health. This seems to not be a problem as regards depression, but for other conditions there are more mixed results. 40 Future studies on ACT, acceptance and commitment therapy; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-years; WDI, workplace dialogue intervention.
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mental health disorders may want to consider using other multiattribute utility instruments that are sensitive to domains of mental health and can more appropriately capture effects on health-related quality-of-life. Further, in the cost-utility analysis, nonsignificant mean differences in QALYs gained were used. This may be questioned, nonetheless, it may not be appropriate to conclude that a nonsignificant difference equals zero difference. 23 It is argued that in order to maximize health gain for a given budget, interventions should be selected based on the mean net benefit, that is, the benefit of paying less for a good, irrespective of significant differences between them. 41 For these reasons, the uncertainty around point estimates was handled and illustrated with the cost-effectiveness plane and CEACs, as well as by providing CIs and P values of differences between treatment groups as proposed by. 42 Further, despite having a decent sample size overall, no power analysis was conducted for the economic evaluation, thus the study may have been underpowered. Because the distribution of cost data typically is heavily skewed in economic evaluations conducted alongside RCTs, large study populations are needed. This is reflected in the rather wide CIs for cost data in this study. As for subgroups, this means that there are problems with drawing conclusions for diagnostic groups. Inevitably in subgroup analyses, the samples become smaller, and the subgroup specific estimates of parameters are less precise than the group-level estimates. These estimates should therefore be evaluated further in future research before final conclusions may be drawn. Finally, no information was collected on the costs of workplace adaptations that might have resulted from the WDI intervention. This might have caused an underestimation of the intervention costs for WDI and ACTþWDI.
CONCLUSION
The results of this study suggest that ACT is the most costeffective treatment alternative in this trial for employees on sickness absence due to mental disorders. WDI cannot be regarded as costeffective, and adding WDI to ACT may not be a cost-effective use of limited resources either from a health care or from a limited societal perspective. Despite a high WTP, the probability of cost-effectiveness reaches a maximum of 50% for ACTþWDI. Because this is the first study to examine cost-effectiveness of ACT and WDI for this population, further research is necessary to determine the costeffectiveness of adding a workplace intervention to psychotherapy. Overall, implementation of ACT, WDI, or a combination of the two for employees on sickness absence due to common mental health problems cannot be recommended on the basis of our study results.
